特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
市場調査レポート
商品コード
928583

癒着防止剤:世界市場の見通し(2018年~2027年)

Adhesion Barrier - Global Market Outlook (2018-2027)

出版日: | 発行: Stratistics Market Research Consulting | ページ情報: 英文 135 Pages | 納期: 2-3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=105.15円
癒着防止剤:世界市場の見通し(2018年~2027年)
出版日: 2020年02月20日
発行: Stratistics Market Research Consulting
ページ情報: 英文 135 Pages
納期: 2-3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の癒着防止剤市場は、2018年に5億8,221万米ドルとなりました。同市場は、予測期間中に8.5%のCAGRで成長する見通しで、2027年までに12億1,324万米ドルに達すると予測されています。同市場の成長に影響を与える主要な要因には、老年人口の増加と加齢性慢性疾患、外科的処置とスポーツ関連のけがの増加、癒着の医学的影響についての意識の高まりなどが挙げられます。ただし、外科医の間での癒着防止剤使用への消極性は、同市場の成長を抑制しています。

当レポートは世界の癒着防止剤市場について調査しており、市場動向や脅威、成長および抑制要因、剤形・製品・成分・タイプ・用途・エンドユーザー・地域別の市場分析、競合情勢、主要企業のプロファイル等の情報を提供しています。

目次

第1章 エグゼクティブサマリー

第2章 イントロダクション

第3章 市場動向分析

  • イントロダクション
  • 成長要因
  • 抑制要因
  • 市場機会
  • 脅威
  • 製品分析
  • 用途分析
  • エンドユーザー分析
  • 新興市場
  • 今後の市場シナリオ

第4章 ポーターのファイブフォース分析

第5章 世界市場:剤形別

  • イントロダクション
  • ゲル製剤
  • 液体製剤
  • フィルム/メッシュ製剤

第6章 世界市場:製剤別

  • イントロダクション
  • 天然
    • フィブリン
    • コラーゲン・タンパク質
  • 合成
    • ポリエチレングリコール
    • ヒアルロン酸
    • 再生セルロース
    • その他
  • MediShield
  • Seprafilm
  • DuraGen Plus
  • Gynecare Interceed
  • Oxiplex
  • Adept
  • Hyalobarrier
  • 4DryFieldPH
  • SprayShield

第7章 世界市場:成分別

  • イントロダクション
  • ポリヒドロキシアルカノエート(PHA)
  • ポリエーテルエーテルケトン(PEEK)
  • シリコーン
  • ミクロスフェア
  • 分散剤

第8章 世界市場:タイプ別

  • イントロダクション
  • 止血
  • 内部組織シーラント

第9章 世界市場:用途別

  • イントロダクション
  • 整形外科
  • 神経外科
  • 婦人科手術
  • 再建手術
  • 一般/腹部手術
  • 泌尿器科手術
  • 心臓血管外科
  • 胸部外科
  • その他
    • 喉の手術
    • 鼻の外科
    • 熱傷手術
    • 耳の外科

第10章 世界市場:エンドユーザー別

  • イントロダクション
  • 病院
  • 救急医療サービス
  • 外来手術センター
  • 専門クリニック
  • クリニック・外傷センター

第11章 世界市場: 地域別

  • イントロダクション
  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • 英国
    • イタリア
    • フランス
    • スペイン
    • その他
  • アジア太平洋地域
    • 日本
    • 中国
    • インド
    • オーストラリア
    • ニュージーランド
    • 韓国
    • その他
  • 南米
    • アルゼンチン
    • ブラジル
    • チリ
    • その他
  • 中東・アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • カタール
    • 南アフリカ
    • その他

第12章 主な開発

  • 契約、提携、協業、合弁事業
  • 買収と合併
  • 新製品の発売
  • 拡張
  • その他の主な戦略

第13章 企業プロファイル

  • Anika Therapeutics, Inc.,
  • Sanofi Group
  • PlantTec Medical GmbH
  • C. R. Bard, Inc.
  • Medtronic Plc
  • Johnson & Johnson
  • FzioMed, Inc.,
  • Becton Dickinson and Company
  • Baxter International, Inc.,
  • MAST Biosurgery AG
  • Integra LifeSciences Holdings Corporation
  • Getinge AB
  • Betatech Medical
  • Innocoll Holdings
  • Ethicon US, LLC
図表

List of Tables

  • Table 1 Global Adhesion Barrier Market Outlook, By Region (2017-2027) ($MN)
  • Table 2 Global Adhesion Barrier Market Outlook, By Formulation (2017-2027) ($MN)
  • Table 3 Global Adhesion Barrier Market Outlook, By Gel Formulations (2017-2027) ($MN)
  • Table 4 Global Adhesion Barrier Market Outlook, By Liquid Formulations (2017-2027) ($MN)
  • Table 5 Global Adhesion Barrier Market Outlook, By Film/Mesh Formulations (2017-2027) ($MN)
  • Table 6 Global Adhesion Barrier Market Outlook, By Product (2017-2027) ($MN)
  • Table 7 Global Adhesion Barrier Market Outlook, By Natural Adhesion Barriers (2017-2027) ($MN)
  • Table 8 Global Adhesion Barrier Market Outlook, By Fibrin (2017-2027) ($MN)
  • Table 9 Global Adhesion Barrier Market Outlook, By Collagen & Protein (2017-2027) ($MN)
  • Table 10 Global Adhesion Barrier Market Outlook, By Synthetic Adhesion Barriers (2017-2027) ($MN)
  • Table 11 Global Adhesion Barrier Market Outlook, By Polyethylene Glycol (2017-2027) ($MN)
  • Table 12 Global Adhesion Barrier Market Outlook, By Hyaluronic Acid (2017-2027) ($MN)
  • Table 13 Global Adhesion Barrier Market Outlook, By Regenerated Cellulose (2017-2027) ($MN)
  • Table 14 Global Adhesion Barrier Market Outlook, By Other Synthetic Adhesion Barrers (2017-2027) ($MN)
  • Table 15 Global Adhesion Barrier Market Outlook, By MediShield (2017-2027) ($MN)
  • Table 16 Global Adhesion Barrier Market Outlook, By Seprafilm (2017-2027) ($MN)
  • Table 17 Global Adhesion Barrier Market Outlook, By Duragen Plus (2017-2027) ($MN)
  • Table 18 Global Adhesion Barrier Market Outlook, By Gynecare Interceed (2017-2027) ($MN)
  • Table 19 Global Adhesion Barrier Market Outlook, By Oxiplex (2017-2027) ($MN)
  • Table 20 Global Adhesion Barrier Market Outlook, By Adept (2017-2027) ($MN)
  • Table 21 Global Adhesion Barrier Market Outlook, By Hyalobarrier (2017-2027) ($MN)
  • Table 22 Global Adhesion Barrier Market Outlook, By 4DryFieldPH (2017-2027) ($MN)
  • Table 23 Global Adhesion Barrier Market Outlook, By SprayShield (2017-2027) ($MN)
  • Table 24 Global Adhesion Barrier Market Outlook, By Ingredient (2017-2027) ($MN)
  • Table 25 Global Adhesion Barrier Market Outlook, By Polyhydroxyalkanoate (PHA) (2017-2027) ($MN)
  • Table 26 Global Adhesion Barrier Market Outlook, By Polyether Ether Ketone (PEEK) (2017-2027) ($MN)
  • Table 27 Global Adhesion Barrier Market Outlook, By Silicone (2017-2027) ($MN)
  • Table 28 Global Adhesion Barrier Market Outlook, By Microsphere (2017-2027) ($MN)
  • Table 29 Global Adhesion Barrier Market Outlook, By Dispersants (2017-2027) ($MN)
  • Table 30 Global Adhesion Barrier Market Outlook, By Type (2017-2027) ($MN)
  • Table 31 Global Adhesion Barrier Market Outlook, By Hemostats (2017-2027) ($MN)
  • Table 32 Global Adhesion Barrier Market Outlook, By Internal Tissue Sealants (2017-2027) ($MN)
  • Table 33 Global Adhesion Barrier Market Outlook, By Application (2017-2027) ($MN)
  • Table 34 Global Adhesion Barrier Market Outlook, By Orthopedic Surgeries (2017-2027) ($MN)
  • Table 35 Global Adhesion Barrier Market Outlook, By Neurological Surgeries (2017-2027) ($MN)
  • Table 36 Global Adhesion Barrier Market Outlook, By Gynecological Surgeries (2017-2027) ($MN)
  • Table 37 Global Adhesion Barrier Market Outlook, By Reconstructive Surgeries (2017-2027) ($MN)
  • Table 38 Global Adhesion Barrier Market Outlook, By General/Abdominal Surgeries (2017-2027) ($MN)
  • Table 39 Global Adhesion Barrier Market Outlook, By Urological Surgeries (2017-2027) ($MN)
  • Table 40 Global Adhesion Barrier Market Outlook, By Cardiovascular Surgeries (2017-2027) ($MN)
  • Table 41 Global Adhesion Barrier Market Outlook, By Thoracic Surgeries (2017-2027) ($MN)
  • Table 42 Global Adhesion Barrier Market Outlook, By Other Surgeries (2017-2027) ($MN)
  • Table 43 Global Adhesion Barrier Market Outlook, By Throat Surgery (2017-2027) ($MN)
  • Table 44 Global Adhesion Barrier Market Outlook, By Nose Surgery (2017-2027) ($MN)
  • Table 45 Global Adhesion Barrier Market Outlook, By Burn Surgery (2017-2027) ($MN)
  • Table 46 Global Adhesion Barrier Market Outlook, By Ear Surgery (2017-2027) ($MN)
  • Table 47 Global Adhesion Barrier Market Outlook, By End User (2017-2027) ($MN)
  • Table 48 Global Adhesion Barrier Market Outlook, By Hospitals (2017-2027) ($MN)
  • Table 49 Global Adhesion Barrier Market Outlook, By Emergency Care Services (2017-2027) ($MN)
  • Table 50 Global Adhesion Barrier Market Outlook, By Ambulatory Surgical Centers (2017-2027) ($MN)
  • Table 51 Global Adhesion Barrier Market Outlook, By Specialty Clinics (2017-2027) ($MN)
  • Table 52 Global Adhesion Barrier Market Outlook, By Clinics & Trauma Centers (2017-2027) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.

目次

According to Stratistics MRC, the Global Adhesion Barrier Market is accounted for $582.21 million in 2018 and is expected to reach $1,213.24 million by 2027 growing at a CAGR of 8.5% during the forecast period. Some of the key factors influencing the market growth include growth in the geriatric population and corresponding age-related chronic diseases, growing volume of surgical procedures and sports-related injuries, and increasing awareness about the medical implications of adhesions. However, reluctance towards the usage of adhesion barriers among surgeons is restraining market growth.

Adhesion barrier is a medical device that is used to reduce abnormal internal scarring following surgery by separating the internal tissues and organs. Adhesion barriers are used in the abdominal, gynaecological, orthopaedic, cardiovascular, reconstructive, and urological surgeries. Adhesion barriers are mostly used in cardiovascular surgeries to heal the coronary artery. The gel and film formulations of adhesion barriers are widely used as compared to the liquid formulation. The application of adhesion barriers is increasing with the increasing number of surgical procedures.

Based on the formulation, the film formulations segment is expected to grow at the considerable rate during the forecast period, due to the growing number of surgical procedures utilizing film-form adhesion barriers and the higher adoption of film-form adhesion barriers by surgeons due to their low cost. The availability of clinical evidence supporting the safety and efficacy of these forms of adhesion barriers further boost the growth of this market.

By Geography, North America is expected to have a lucrative growth during the forecast period, due to increase in the incidence of chronic diseases associated with an ageing population, increase in the volume of surgical procedures, well-established healthcare services, and higher public and private healthcare expenditure. Moreover, the increase in the prevalence of orthopaedic conditions coupled with high adoption of advanced treatment procedures is anticipated to fuel market growth in the U.S.

Some of the key players in global Adhesion Barrier market are Anika Therapeutics, Inc., Sanofi Group, PlantTec Medical GmbH, C. R. Bard, Inc., Medtronic Plc, Johnson & Johnson, FzioMed, Inc., Becton Dickinson and Company, Baxter International, Inc., MAST Biosurgery AG, Integra LifeSciences Holdings Corporation, Getinge AB, Betatech Medical, Innocoll Holdings, and Ethicon US, LLC.

Formulations Covered:

  • Gel Formulations
  • Liquid Formulations
  • Film/Mesh Formulations

Products Covered:

  • Natural Adhesion Barriers
  • Synthetic Adhesion Barriers
  • MediShield
  • Seprafilm
  • Duragen Plus
  • Gynecare Interceed
  • Oxiplex
  • Adept
  • Hyalobarrier
  • 4DryFieldPH
  • SprayShield

Ingredients Covered:

  • Polyhydroxyalkanoate (PHA)
  • Polyether Ether Ketone (PEEK)
  • Silicone
  • Microsphere
  • Dispersants

Types Covered:

  • Hemostats
  • Internal Tissue Sealants

Applications Covered:

  • Orthopaedic Surgeries
  • Neurological Surgeries
  • Gynaecological Surgeries
  • Reconstructive Surgeries
  • General/Abdominal Surgeries
  • Urological Surgeries
  • Cardiovascular Surgeries
  • Thoracic Surgeries
  • Other Surgeries

End Users Covered:

  • Hospitals
  • Emergency Care Services
  • Ambulatory Surgical Centers
  • Speciality Clinics
  • Clinics & Trauma Centers

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2017, 2018, 2019, 2023 and 2027
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic analysis: Drivers and Constraints, Product/Technology Analysis, Porter's five forces analysis, SWOT analysis, etc.
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Application Analysis
  • 3.8 End User Analysis
  • 3.9 Emerging Markets
  • 3.10 Futuristic Market Scenario

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Adhesion Barrier Market, By Formulation

  • 5.1 Introduction
  • 5.2 Gel Formulations
  • 5.3 Liquid Formulations
  • 5.4 Film/Mesh Formulations

6 Global Adhesion Barrier Market, By Product

  • 6.1 Introduction
  • 6.2 Natural Adhesion Barriers
    • 6.2.1 Fibrin
    • 6.2.2 Collagen & Protein
  • 6.3 Synthetic Adhesion Barriers
    • 6.3.1 Polyethylene Glycol
    • 6.3.2 Hyaluronic Acid
    • 6.3.3 Regenerated Cellulose
    • 6.3.4 Other Synthetic Adhesion Barrers
      • 6.3.4.1 Silicon Rubber
      • 6.3.4.2 Hydrogel
      • 6.3.4.3 Polyethylene Oxide
      • 6.3.4.4 Icodextrin
      • 6.3.4.5 Expended Polytetrafluroethylene (ePTFE) Membrane
      • 6.3.4.6 Corboxynethylcellulose
  • 6.4 MediShield
  • 6.5 Seprafilm
  • 6.6 Duragen Plus
  • 6.7 Gynecare Interceed
  • 6.8 Oxiplex
  • 6.9 Adept
  • 6.10 Hyalobarrier
  • 6.11 4DryFieldPH
  • 6.12 SprayShield

7 Global Adhesion Barrier Market, By Ingredient

  • 7.1 Introduction
  • 7.2 Polyhydroxyalkanoate (PHA)
  • 7.3 Polyether Ether Ketone (PEEK)
  • 7.4 Silicone
  • 7.5 Microsphere
  • 7.6 Dispersants

8 Global Adhesion Barrier Market, By Type

  • 8.1 Introduction
  • 8.2 Hemostats
  • 8.3 Internal Tissue Sealants

9 Global Adhesion Barrier Market, By Application

  • 9.1 Introduction
  • 9.2 Orthopedic Surgeries
  • 9.3 Neurological Surgeries
  • 9.4 Gynecological Surgeries
  • 9.5 Reconstructive Surgeries
  • 9.6 General/Abdominal Surgeries
  • 9.7 Urological Surgeries
  • 9.8 Cardiovascular Surgeries
  • 9.9 Thoracic Surgeries
  • 9.10 Other Surgeries
    • 9.10.1 Throat Surgery
    • 9.10.2 Nose Surgery
    • 9.10.3 Burn Surgery
    • 9.10.4 Ear Surgery

10 Global Adhesion Barrier Market, By End User

  • 10.1 Introduction
  • 10.2 Hospitals
  • 10.3 Emergency Care Services
  • 10.4 Ambulatory Surgical Centers
  • 10.5 Specialty Clinics
  • 10.6 Clinics & Trauma Centers

11 Global Adhesion Barrier Market, By Geography

  • 11.1 Introduction
  • 11.2 North America
    • 11.2.1 US
    • 11.2.2 Canada
    • 11.2.3 Mexico
  • 11.3 Europe
    • 11.3.1 Germany
    • 11.3.2 UK
    • 11.3.3 Italy
    • 11.3.4 France
    • 11.3.5 Spain
    • 11.3.6 Rest of Europe
  • 11.4 Asia Pacific
    • 11.4.1 Japan
    • 11.4.2 China
    • 11.4.3 India
    • 11.4.4 Australia
    • 11.4.5 New Zealand
    • 11.4.6 South Korea
    • 11.4.7 Rest of Asia Pacific
  • 11.5 South America
    • 11.5.1 Argentina
    • 11.5.2 Brazil
    • 11.5.3 Chile
    • 11.5.4 Rest of South America
  • 11.6 Middle East & Africa
    • 11.6.1 Saudi Arabia
    • 11.6.2 UAE
    • 11.6.3 Qatar
    • 11.6.4 South Africa
    • 11.6.5 Rest of Middle East & Africa

12 Key Developments

  • 12.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 12.2 Acquisitions & Mergers
  • 12.3 New Product Launch
  • 12.4 Expansions
  • 12.5 Other Key Strategies

13 Company Profiling

  • 13.1 Anika Therapeutics, Inc.,
  • 13.2 Sanofi Group
  • 13.3 PlantTec Medical GmbH
  • 13.4 C. R. Bard, Inc.
  • 13.5 Medtronic Plc
  • 13.6 Johnson & Johnson
  • 13.7 FzioMed, Inc.,
  • 13.8 Becton Dickinson and Company
  • 13.9 Baxter International, Inc.,
  • 13.10 MAST Biosurgery AG
  • 13.11 Integra LifeSciences Holdings Corporation
  • 13.12 Getinge AB
  • 13.13 Betatech Medical
  • 13.14 Innocoll Holdings
  • 13.15 Ethicon US, LLC
株式会社グローバルインフォメーション
© Copyright 1996-2020, Global Information, Inc. All rights reserved.